 |
 Video: What is a Stock Split?
|
|
|
| Lexaria Bioscience is a biotechnology company pursuing the enhancement of the bioavailability of a range of active pharmaceutical ingredients (API) using its proprietary DehydraTECH drug delivery technology. Co.'s patent portfolio includes patent family applications or grants pertaining to Co.'s method of improving bioavailability and taste, and the use of DehydraTECH as a delivery platform for a variety of APIs encompassing all cannabinoids including tetrahydrocannabinol; fat soluble vitamins; non-steroidal anti-inflammatory drugs pain medications; and nicotine and its analogs. Co. has identified two reportable segments: Intellectual Property Licensing and B2B Production. According to our Lexaria Bioscience stock split history records, Lexaria Bioscience has had 0 splits. | |
|
Lexaria Bioscience (LEXX) has 0 splits in our Lexaria Bioscience stock split history database.
Looking at the Lexaria Bioscience stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Lexaria Bioscience shares, starting with a $10,000 purchase of LEXX, presented on a split-history-adjusted basis factoring in the complete Lexaria Bioscience stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/13/2021 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$4.40 |
|
| End price/share: |
$2.35 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-46.59% |
|
| Average Annual Total Return: |
-17.39% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,341.77 |
|
| Years: |
3.28 |
|
|
|
|
|
